Home/Pipeline/AUR-102

AUR-102

MYC‑driven cancers

PreclinicalActive

Key Facts

Indication
MYC‑driven cancers
Phase
Preclinical
Status
Active
Company

About Aurigene Pharmaceutical Services

Aurigene delivers AI‑enabled drug‑discovery services and a growing oncology pipeline for pharma partners.

View full company profile

Therapeutic Areas